Analysis of the efficacy and safety of a combined gemcitabine, oxaliplatin and pegaspargase regimen for NK/T-cell lymphoma
about
Analysis of the efficacy and safety of a combined gemcitabine, oxaliplatin and pegaspargase regimen for NK/T-cell lymphoma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Analysis of the efficacy and s ...... regimen for NK/T-cell lymphoma
@en
Analysis of the efficacy and s ...... egimen for NK/T-cell lymphoma.
@nl
type
label
Analysis of the efficacy and s ...... regimen for NK/T-cell lymphoma
@en
Analysis of the efficacy and s ...... egimen for NK/T-cell lymphoma.
@nl
prefLabel
Analysis of the efficacy and s ...... regimen for NK/T-cell lymphoma
@en
Analysis of the efficacy and s ...... egimen for NK/T-cell lymphoma.
@nl
P2093
P2860
P356
P1433
P1476
Analysis of the efficacy and s ...... regimen for NK/T-cell lymphoma
@en
P2093
Hui-Qiang Huang
Jing-Hua Wang
Wen-Qi Jiang
Yan-Jun Wang
Zhong-Jun Xia
P2860
P304
35412-35422
P356
10.18632/ONCOTARGET.8643
P407
P577
2016-04-07T00:00:00Z